• Profile
Close

Additional treatments, satisfaction, symptoms and quality of life in women 1 year after vaginal and abdominal pelvic organ prolapse repair

International Urology and Nephrology Mar 22, 2018

Nguyen LN, et al. - In this review experts sought to assess additional treatments, symptoms, satisfaction, and quality of life 1 year following vaginal and abdominal-pelvic organ prolapse (POP) repair. Improvement was noted in the symptoms and most women were satisfied with surgery. Nonetheless, in the first year after POP repair, about 1 in 2 women had additional therapy.

Methods

  • Researchers reviewed the adult women enrolled in a prospective POP database.
  • They collected the baseline and outcomes data 1 year following surgery including the Pelvic Floor Distress Inventory (PFDI) and mailed surveys.
  • Descriptive statistics, Fisher’s exact tests and t tests were used to analyze the data.

Results

  • Results suggested that out of 222 women, 147 (66%) had vaginal and 75 (34%) had abdominal repair.
  • As per the data, vaginal group patients were older (64.1 vs 59.7 years; p=0.003), but other demographic characteristics did not differ.
  • Lower baseline anterior and apical prolapse grades were noted in vaginal group patients (anterior 2.7 vs 3.1, p=0.003; apical 2.1 vs 3.1, p < 0.001).
  • Similar baseline PFDI scores were seen.
  • After 1 year, scores improved significantly for both the groups, but 1-year PFDI scores were notably higher in the vaginal group (45.6 vs 32.6, p=0.032).
  • When adjusted for age and prolapse grade, scores were not different (p=0.24).
  • Most patients in the vaginal and abdominal groups reported moderately/markedly improved overall symptoms (72/108 vs 50/60, p=0.030) and quality of life (89/101 vs 54/59, p=0.601), at 1 year.
  • Most patients were noted to be satisfied with the surgery (68/101 vs 48/59, p=0.067).
  • Findings demonstrated the retreatment rates (pelvic floor physical therapy, medications, coping strategies, surgical procedures) to be similar (34/109 vs 15/62, p=0.381).
  • Additional treatments, patient satisfaction or symptoms were not affected by use of the vaginal mesh.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay